Periarticular bone findings in rheumatoid arthritis: T2-weighted versus contrast-enhanced T1-weighted MRI

Lawrence Yao1, Michael Magalnick, Mildred Wilson

  • 1Diagnostic Radiology Department, National Institutes of Health, 10 Center Drive, Room 1C640, Bethesda, MD 20892-1182, USA.

Abstract

Insights

Contrast-enhanced T1-weighted MRI shows more bone abnormalities in rheumatoid arthritis patients than T2-weighted MRI. Both MRI techniques accurately predict CT-evident erosive disease.

Area of Science:

  • Radiology
  • Orthopedics
  • Rheumatology

Background:

  • Rheumatoid arthritis (RA) commonly affects the wrist, leading to bone erosions.
  • Magnetic Resonance Imaging (MRI) is valuable for detecting periarticular bone abnormalities in RA.
  • Comparing different MRI sequences is crucial for optimizing diagnostic accuracy.

Purpose of the Study:

  • To compare the predictive value of T2-weighted and contrast-enhanced T1-weighted MRI for CT-evident bone erosions in RA.
  • To evaluate the sensitivity of each MRI technique in detecting periarticular bone marrow signal alterations.

Main Methods:

  • Eleven RA patients underwent CT and MRI of the wrist.
  • T2-weighted MRI with spectral fat saturation and contrast-enhanced T1-weighted MRI (gadolinium-based contrast) were performed.
  • Imaging data were analyzed for 15 anatomic zones, scoring bone erosion on CT and bone marrow signal alteration on MRI.

Main Results:

  • Both MRI techniques showed good concordance with CT for bone abnormalities (74%).
  • Contrast-enhanced T1-weighted MRI identified significantly more abnormalities (38 zones) than T2-weighted MRI (5 zones) in discordant cases (p < 0.001).
  • T2-weighted images often showed edema-like patterns, while contrast-enhanced T1-weighted MRI was more sensitive to subtle bone marrow changes.

Conclusions:

  • Contrast-enhanced T1-weighted MRI is more sensitive than fat-suppressed T2-weighted MRI for detecting periarticular bone abnormalities in RA.
  • Both MRI techniques demonstrate equal predictive value for established, CT-visible erosive disease.